Form 4: Twist Bioscience Officer Sells Shares for Tax Obligations

Dennis Cho, SVP and Chief Legal Officer of Twist Bioscience, sold 1,099 shares to cover tax withholding obligations related to RSU vesting.

Summary

• Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp (TWST), reported a transaction on February 3, 2026.
• The transaction involved the disposition of 1,099 shares of Common Stock at a price of $46.576 per share.
• This sale was explicitly identified as a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs).
• The transaction does not represent a discretionary trade by Mr. Cho.
• Following this transaction, Mr. Cho beneficially owns 143,581 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transaction is a routine, non-discretionary 'sell to cover' for tax purposes, which does not reflect a change in the executive's investment sentiment or the company's operational performance.

Positives

• The transaction is a routine 'sell to cover' for tax obligations, indicating the vesting of Restricted Stock Units (RSUs) for the executive, which is a standard component of executive compensation plans.

Negatives

• The sale of shares, while non-discretionary, reduces the executive's direct equity stake in the company by 1,099 shares.

Future Outlook

N/A

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and routine occurrence for executives receiving equity compensation. They are typically non-discretionary sales executed to satisfy tax liabilities upon the vesting of restricted stock units or the exercise of stock options, and generally do not signal a change in management's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.

Key Dates

Recommendation

This Form 4 filing details a routine 'sell to cover' transaction by an executive to satisfy tax obligations upon RSU vesting. It is explicitly stated as non-discretionary and does not reflect a change in the executive's investment thesis or the company's outlook. Therefore, it provides no new fundamental information to warrant a change in investment recommendation, suggesting a 'hold' position for existing investors.

Keywords

Twist Bioscience, TWST, Dennis Cho, Insider Trading, Form 4, Sell to Cover, Restricted Stock Units, Executive Compensation, Tax Withholding